# Sodium Bicarbonate in Intra-dialytic Hypertension in Chronic Hemodialysis Patients

> **NCT07231900** · PHASE2,PHASE3 · NOT_YET_RECRUITING · sponsor: **Assaf-Harofeh Medical Center** · enrollment: 40 (estimated)

## Conditions studied

- Hypertension in Dialysis Patients

## Interventions

- **DRUG:** Sodium Bicarbonate (NaHCO3)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07231900
- **Lead sponsor:** Assaf-Harofeh Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-11-10
- **Primary completion:** 2027-12-01
- **Final completion:** 2027-12-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07231900

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07231900, "Sodium Bicarbonate in Intra-dialytic Hypertension in Chronic Hemodialysis Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07231900. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*